Polymers News and Research

RSS

Nano-sized particles enable researchers to visualize a tumor using only infrared light

Nano-sized particles embedded with bright, light-emitting molecules have enabled researchers to visualize a tumor more than one centimeter below the skin surface using only infrared light.

7 Feb 2005

New method of delivery of gene therapy may lead to safer treatment for cancer

The Lankenau Institute for Medical Research (LIMR) announced that in collaboration with the Massachusetts Institute of Technology (MIT) they have performed preclinical proof-of- principle studies showing how nanotechnology can be used to enhance gene therapy for cancer.

25 Jan 2005

Biodegradable mosquito trap - latest weapon against the spread of dengue fever

University of Queensland researchers are working with a biodegradable packaging business, < Plantic>, James Cook University and Queensland Health to design and produce the traps.

18 Jan 2005

Honeycomb-like polymer implant helps re-build the faces of children

British and Russian surgeons are using a revolutionary honeycomb-like polymer implant to help re-build the faces of children injured in accidents or born with serious defects. The material bonds with bone without causing adverse reactions.

12 Jan 2005

Novel approach to bioengineer artificial skin for burn victims

Each year more than 45,000 Americans suffer burns serious enough to require a hospital stay, according to the American Burn Association. While the traditional therapy of using skin grafts to cover burn sites has improved, a number of problems including scarring, infection and poor adhesion remain.

4 Jan 2005

New DNA sequence translation device

Chemists at New York University have developed a device that allows for the translation of DNA sequences, thereby serving as a factory for assembling the building blocks of new materials.

21 Dec 2004

Biological clock affects the patterns of heart-rate control in healthy individuals

In a newly reported, first-ever finding, physicists from Boston University and physiologists from Boston’s Brigham and Women’s Hospital (BWH) have found that the body’s biological clock affects the patterns of heart-rate control in healthy individuals independent of sleep/wake cycle or other behavior influences.

21 Dec 2004

Wide angle X-ray scattering (WAXS) could help produce lead drugs for disease therapy

Structural changes in proteins can now be seen in increased detail, using a new application of an existing technique. The application, developed at the U.S. Department of Energy's Argonne National Laboratory, could help produce lead drugs for disease therapy.

8 Dec 2004

Scene-of-the-crime DNA analysis is moving a step closer

Currently DNA analysis is both time-consuming and expensive, but researchers at the Polymer Electronics Research Centre (PERC), within the Faculty of Science and the Faculty of Medical and Health Sciences, hope to change that by inventing a system that provides direct, real-time detection of DNA.

4 Dec 2004

Scientists create world’s smallest test tube

Oxford scientists have made it into the Guinness Book of World Records by making the world’s smallest test tube – so tiny that around 300 billion would fit onto a full stop on this page.

24 Nov 2004

World’s strongest acid may have a role in synthesizing pharmaceuticals

Researchers at the University of California, Riverside have discovered the world’s strongest acid. Remarkably it is also the gentlest acid. This non-toxic and non-corrosive acid may have a role in processes such as improving the quality of gasoline, developing polymers and synthesizing pharmaceuticals.

16 Nov 2004

New journal offering free access publishing and what is believed to be a unique development in the field of scientific publishing

Uniquely providing totally free access to scientific publications, and offering financial rewards for both authors and peer reviewers

19 Oct 2004

Research has identified Dectin-1 as the beta-glucan receptor on immune cells

This finding may be of use in the prophylactic prevention of a variety of infections, especially in surgical patients, and in the treatment of cancer. The identification of Dectin-1 as the beta-glucan receptor may also provide a novel strategy for combating fungal infections.

10 Oct 2004

Microfluidics help lab-on-a-chip development skyrocket

Lab-on-a-chip (LOC) development has skyrocketed in the last couple of years due to constant efforts in harnessing microfluidics and µTAS to improve the LOC design and function. The distinct advantages that they bestow on applications are pushing the commercial potential of LOCs.

28 Sep 2004

High tech implants to aid facial reconstruction

Loughborough University researchers have been awarded more than £200,000 to develop state-of-the-art tailor made implants for people requiring facial reconstructive surgery.

27 Aug 2004

Signet Laboratories has announced the release of ACUITY mouse-on-mouse polymer detection system

Signet's ACUITY(TM) Mouse-on-Mouse Polymer Detection System is a sensitive biotin-free detection system for use with monoclonal and polyclonal antibodies on mouse or rat tissue. ACUITY(TM) Mouse-on-Mouse provides cost savings by enabling researchers to use less antibody, while increasing staining intensity and eliminating background.

9 Aug 2004

A drug derived from an ocean-growing sponge helps prevent the growth of cancer cells

A drug derived from an ocean-growing sponge teams up to enhance the performance of the yew tree derivative Taxol® (paclitaxel) in preventing the growth of cancer cells, according to research published in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Biocompatibility of interactions that occur between implanted biomaterials and the host living tissue

Researchers across the world are working toward biocompatibility by optimizing interactions that occur between implanted biomaterials and the host living tissue.

21 Jun 2004

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Labopharm Inc. today announced that it has entered into an agreement with Debiopharm S.A. under which Debiopharm has engaged Labopharm to conduct research on the potential oral delivery of a current intravenous cancer drug using Labopharm’s proprietary polymeric nano-delivery systems technology (also referred to as micelles technology).

16 Jun 2004

Eastern Plastics Incorporation allowed to sell components produced from OXPEKK® implantable polymer

Oxford Performance Materials, Inc. (OPM) and Eastern Plastics Incorporation (EPI) have come to an agreement which enables EPI to sell machined components produced from OXPEKK® implantable polymer. OPM's OXPEKK-IG products have undergone ISO-10993 biocompatibility testing and are supported by a FDA Masterfile.

7 Jun 2004